Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2005
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005US20050245408 Sustained release; controlled chemical cascade; storage stability
11/03/2005CA2563756A1 Phenyl acetamides
11/03/2005CA2563330A1 A process for the preparation of 2,2-disubstituted pyrroles
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/02/2005EP1591832A2 Photosensitive composition, compound used in the same, and patterning method using the same
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590329A1 N-aryl heteroaromatic products, compositions containing same and use thereof
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590324A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
11/02/2005EP1590314A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/02/2005EP1334084A4 Phosgene-free process for preparing carbamates
11/02/2005EP1311518B1 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005CN1692118A Olefin polymerization catalysts containing a pyrrole bisimine ligand
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1692099A Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2, 4-dione derivatives serving as pesticides
11/02/2005CN1689405A Compounds, compositions, and methods for controlling biofilms
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960667 Such as 1,1'-(1,2-ethanediyl)bis(3,4-diphenyl)-1H-pyrrole-2,5-dione; improved photostability
11/01/2005US6960636 Does not require solvent to provide viscosity for handling; low moisture uptake; for adhesives
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
10/2005
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100313A1 Process for forming amorphous atorvastatin calcium
10/27/2005WO2005100311A1 Bicyclic aromatic sulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005087763A9 Diphenylmethyl compounds useful as muscarinic receptor antagonists
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005US20050240028 Pyrrolyl complexes of copper for copper metal deposition
10/27/2005US20050240015 Solution phase synthesis of oligonucleotides
10/27/2005US20050239887 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
10/27/2005US20050239872 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239869 calcium atorvastatin (Lipitor) intermediate; from intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation (patent indexing)
10/27/2005US20050239862 Amino ceramide-like compounds and therapeutic methods of use
10/27/2005US20050239861 Administering isolated and optically active 4-amino-5-chloro-2-methoxy-N-[(2S,4S)- 2-hydroxymethyl-4-pyrrolidinyl]benzamide, which has high binding affinity for a serotonin receptor 4 (5HT4) and does not cause arteritis or thrombus formation for improving movement of digestive tract
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239839 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/27/2005US20050239836 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239801 Novel compounds
10/27/2005US20050239779 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239764 Zinc pyrrolidonecarboxylate dihydrate and method of producing the same
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
10/27/2005US20050238992 Exposure latitude and line-edge roughness
10/27/2005US20050235433 Composition for dyeing keratin fibers with a cationic direct dye and a thickening polymer
10/27/2005CA2562844A1 Process for forming amorphous atorvastatin calcium
10/27/2005CA2561555A1 Bicyclic aromatic sulfinyl derivatives
10/26/2005EP1589002A1 Clausenamide c5 hydroxyl derivatives and n-substituted derivatives, processes for their preparation, its composition and use
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1588145A2 Methods, mixtures, kits and compositions pertaining to analyte determination
10/26/2005EP1587808A1 3-phenyl substituted 3-substituted-4-ketolactams and ketolactones
10/26/2005EP1587798A2 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
10/26/2005EP1587786A1 2.4-DIHALOGEN-6-(C sb 2 /sb -C sb 3 /sb -ALKYL)-PHENYL SUBSTITUTED TETRAMIC ACID DERIVATIVES
10/26/2005EP1587620A1 Hydrogenation catalysts
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1246837B1 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005CN1688741A Pyrrolyl complexes of copper for copper metal deposition
10/26/2005CN1688543A Furanone derivatives and methods of making same
10/26/2005CN1688541A Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1687031A Method for synthesizing imide base substituted endo compound
10/26/2005CN1687030A Complexation method for extracting pyrrolidone or its dissolved substance in organic dilute aqueous solution
10/25/2005US6958384 Polypeptides containing γ-amino acids
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958240 Inhibition of major groove DNA binding proteins by modified polyamides
10/25/2005US6958219 adding a labeled antibody, which binds to the autoinducer having a homoserine lactone ring with an N-acyl side chain, to a lysine-containing protein, and detection of immunospecific binding; N-(3-oxododecanoyl)-L-homoserine lactone
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2157191C Process for the hydrogenation of imines
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097743A1 Synthesis of pyrrole-2-carbonitriles
10/20/2005WO2005097742A1 Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin
10/20/2005WO2005097741A1 Process for the recrystallisation of proline derivates
10/20/2005WO2005097740A1 Histamine h3 receptor agents, preparation and therapeutic uses
10/20/2005WO2005097203A2 Serum protein conjugates of ion channel modulating compounds and uses thereof
10/20/2005WO2005096734A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005WO2005085236A3 Caspase inhibitors and uses thereof
10/20/2005WO2005070919A8 N-type calcium channel blockers
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005US20050234042 Organic compounds
10/20/2005US20050233979 Use in controlling apoptosis, as antiinflammatory agents, in treating autoimmune disease, as antiischemic agents, in treating cardiovascular disorders; for example, (S,S)-3-[2-(3-Acetylamino-2-oxo-2H-pyridin-1-yl)-butyrylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid
10/20/2005US20050233976 Therapeutic methods
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005CA2561967A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 404